Description

Decanoyl-RVKR-CMK (DecRVKRcmk) TFA inhibits over-expressed gp160 processing and HIV-1 replication[1].–80°C, 2 years; -20°C, 1 year (Powder, sealed storage, away from moisture)–COVID-19-anti-virus–C36H67ClF3N11O7—-[1]B Bahbouhi, et al. Inhibition of HIV-2(ROD) replication in a lymphoblastoid cell line by the alpha1-antitrypsin Portland variant (alpha1-PDX) and the decRVKRcmk peptide: comparison with HIV-1(LAI). Microbes Infect. 2001 Nov;3(13):1073-84.|[2]Angelo L Garcia, et al. A prohormone convertase cleavage site within a predicted alpha-helix mediates sorting of the neuronal and endocrine polypeptide VGF into the regulated secretory pathway. J Biol Chem. 2005 Dec 16;280(50):41595-608.–2098497-25-5–858.43–96.40–CCCCCCCCCC(N[C@@H](CCCNC(N)=N)C(N[C@@H](C(C)C)C(N[C@@H](CCCCN)C(N[C@H](C(CCl)=O)CCCNC(N)=N)=O)=O)=O)=O.OC(C(F)(F)F)=O–Infection; Inflammation/Immunology–DMSO : 50 mg/mL (ultrasonic)|H2O : 4 mg/mL (ultrasonic)–HIV–HIV-1;HIV-2–Anti-infection–Peptides